Comparison of in vitro closure time (PFA-100) with whole blood electrical aggregometry and platelet surface antigen expression in healthy volunteers

Thrombosis Research

Volumn 105, Issue 3, 2002, Pages 205-208

  Salat, Andreas ^a   Kroess, Sabine ^a   Felfernig Boehm, Dagmar ^a   Felfernig, Michael ^a   Fleck, Tatjana ^a   Schmidt, Daniela ^a   Pulaki, Sad ^a   Mueller, Michael R ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Aggregometry; Flow cytometry; In vitro closure time; Platelets

Indexed keywords

ADENOSINE DIPHOSPHATE; ANTIGEN; ARACHIDONIC ACID; CD31 ANTIGEN; CD36 ANTIGEN; CD63 ANTIGEN; GLYCOPROTEIN IB ALPHA; PADGEM PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BLOOD CLOTTING TIME; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; HEMOSTASIS; HUMAN; IN VITRO STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SHEAR STRESS; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE MEMBRANE;

ANTIGENS, CD; BLOOD PLATELETS; HEMOSTASIS; HUMANS; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; TIME FACTORS;

EID: 0036474295     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(02)00019-1     Document Type: Article

References (26)

1. Aggregation of blood platelets by adenosine diphosphate and its reversal
2. The electronic aggregometer: A novel device for assessing platelet behaviour in blood
3. Platelet function defects: Simulation of primary hemostasis in vitro
4. Description of an in vitro platelet function analyzer PFA-100
5. European working group on clinical analysis: Consensus protocol for the flowcytometric characterisation of platelet function
6. Computerized acquisition and evaluation of whole blood aggregometry data
7. Influence of hematocrit and platelet count on impedance and reactivity of whole blood for electrical aggregometry
8. Possibility of checking compliance and efficacy of antiaggregatory treatment following femoro-popliteal vein bypass surgery
9. Ultrastructural analysis of the distribution of von Willebrand factor and fibrinogen in platelet aggregates formed in the PTA-100
10. A comparison of the effects of aspirin on bleeding times measured using the Simplate method and closure time measured using the PFA-100, in healthy volunteers
11. Screening for von Willebrand disease with a new analyzer using high shear stress: A study of 60 cases
12. The platelet function analyzer (PFA-100): A novel in-vitro system for evaluation of primary haemostasis in children
13. Changes of platelet surface antigen expression in patients suffering from abdominal septic shock
14. Impaired platelet function correlates with multi-organ dysfunction. A study of patients with sepsis
15. Evidence for abnormal platelet glycoprotein expression in diabetes mellitus
16. Activated platelets in subjects at increased risk of IDDM
17. Platelet abnormalities in diabetes mellitus
18. Large platelets continue to circulate in an activated state after myocardial infarction
19. Elevated plasma glycocalicin levels and decreased ristocetin-induced platelet agglutination in hemodialysis patients
20. Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIb-IIIa receptors
21. Flow cytometric detection of activated platelets in pregnant women prior to the development of pre-eclampsia
22. A quick method for screening platelet dysfunctions using the whole blood lumi-aggregometer
23. Variable platelet responses to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty
24. Relation between inhibition of platelet aggregation and clinical outcome
25. Rapid assessment of platelet function with a modified whole-blood aggregometer in percutaneous transluminal coronary angioplasty patients receiving an anti-GP IIb/IIIa therapy
26. PFA-100 system: A new method for assessment of platelet dysfunction